• RA08371 Indigenous Peoples Rights Act
• RA09711 FDA Act of 2009
• 2009-Guidelines-on-Stem-Cell-ResearchUS-NIH
• 4PNHRS-Joint-Memo (1)
• 20120815-RA-10173-BSA
• FDA-Circular-No.-2012-007
• 8AO2013-0005-DOH-Registry-Diseases
• Administrative-Order-No.-2013-0012
• DOH RERC MEMO 27 Feb 2015
• FC2013-012 Accreditation Stem Cell Facilities
• FDA Circular 2013-020 -Reiteration of Registration of Human Cells, Tissues, and Cellular and Tissue-Based Products.
• FDA-Circular-No.-2013-018
• CHED MEMO 0001 2015_re accreditation
• 20160825-IRR-RA-10173-data-privacy
• PHREB Resolution 20-003 COVID 19 Approval Timelines
• PHREB Resolution 20-005 2
• FDA Circular No. 2016-019
• Inter Office Memo – Oct-29-2020
• PHREB Resolution on COVID-19 Research proposals
• Inter Office Memo -Mar-16-2020
• Inter Office Memo – Jan-20-2021
• FC2020-001-A Medical Devices Classifications
• Inter Office Memo -Jun-18-2021
• Inter Office Memo -Jul-15-2022
• WHO BENCHMARKING tool 9789240076426-eng
• Inter Office Memo – IRB- Memo Review Fees 2024
• 2024 PHREB Policies and Requirements for Accreditation_v1_10
• MMCIRB-Informed-Consent-Template-Guidelines.docx
• Inter Office Memo -Feb-11-2025